D
Dariusz M. Kowalski
Researcher at Curie Institute
Publications - 161
Citations - 12935
Dariusz M. Kowalski is an academic researcher from Curie Institute. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 25, co-authored 129 publications receiving 7930 citations.
Papers
More filters
Journal ArticleDOI
Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland
TL;DR: Results of the TRUST study in the Polish population confirmed the efficacy of erlotinib in advanced NSCLC after failure of prior platinum-based chemotherapy and was associated with longer PFS as compared to the JBR.21.
Journal ArticleDOI
MA10.08 Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC
Balazs Halmos,Alexander Luft,Margarita Majem,Rina Hui,R. Corre,Mahmut Gumus,Konstantin Laktionov,Barbara Hermes,Irfan Cicin,Andrew G. Robinson,Terufumi Kato,Ying Cheng,Dariusz M. Kowalski,Xiaodong Li,Gregory M. Lubiniecki,Bilal Piperdi,Luis Paz-Ares +16 more
Journal ArticleDOI
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients.
Anna Grenda,Paweł Krawczyk,Justyna Błach,Izabela Chmielewska,Tomasz Kubiatowski,Stanisław Kieszko,Kamila Wojas-Krawczyk,Tomasz Kucharczyk,Bożena Jarosz,Iwona Paśnik,Małgorzata Borowiec-Bar,Małgorzata Frąk,Robert Kieszko,Michał Szczyrek,Katarzyna Reszka,Kinga Krukowska,Agnieszka Kolak,Slawomir Mandziuk,Dariusz M. Kowalski,Marek Sawicki,Daria Świniuch,Elżbieta Starosławska,Rodryg Ramlau,Justyna Szumiło,Maciej Krzakowski,Janusz Milanowski +25 more
TL;DR: It is found that patients with PD-L1 expression on ≥1% of tumor cells compared to patients without PD- L1expression on cancer cells had a significantly lower risk of progression and overall survival than patients with low and high expression of these molecules.
Journal Article
Uaktualnione zalecenia dotyczące systemowego leczenia niedrobnokomórkowego raka płuca i złośliwego międzybłoniaka opłucnej
Journal ArticleDOI
Anaemia in cancer patients — Expert Group recommendations
Piotr Radziwon,Maciej Krzakowski,Ewa Kalinka-Warzocha,Renata Zaucha,Piotr J. Wysocki,Dariusz M. Kowalski,Jerzy Gryglewicz,Marek Z. Wojtukiewicz +7 more
TL;DR: Use of ESA reduces the need for red blood cell transfusions, decreases the risk of post-transfusion adverse reactions, and improves quality of life of cancer patients with chemotherapy-induced anaemia.